Related Experiment Video
Updated: Aug 25, 2026
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
Erythrocyte entrapment of daunomycin by amphotericin B without hemolysis
Abstract:
Amphotericin B is a polyene that binds to sterols and perforates cell membranes. An antileukemic drug such as daunomycin added exogenously is impermeable to the red cell membrane. However, when the cells are incubated with a low concentration of amphotericin B, daunomycin is entrapped in the red cells without hemolysis or alteration in the chemical parameter of the erythrocytes. The erythrocyte has been used as a carrier vehicle to enhance the cytotoxic activity of daunomycin against L1210 leukemic cells. In comparison to control preparations, the greatest increase in survival was obtained in vivo when the erythrocytes with entrapped daunomycin were given to C57BL X DBA/2 F1 mice bearing L1210 cells.
Insights
Amphotericin B enables daunomycin loading into red blood cells without damage. This erythrocyte drug delivery system enhanced anti-leukemic activity against L1210 cells in mice.
Area of Science:
- Pharmacology
- Biotechnology
- Oncology
Background:
- Amphotericin B, a polyene antifungal, interacts with cell membranes by binding to sterols.
- Exogenous antileukemic drugs like daunomycin typically cannot penetrate the erythrocyte membrane.
- Erythrocytes (red blood cells) are being explored as potential drug delivery vehicles.
Purpose of the Study:
- To investigate the potential of using erythrocytes as carriers for the antileukemic drug daunomycin.
- To determine if amphotericin B can facilitate daunomycin entrapment in erythrocytes without compromising cell integrity.
- To evaluate the enhanced cytotoxic activity of daunomycin-loaded erythrocytes against L1210 leukemic cells in vivo.
Main Methods:
- Incubating erythrocytes with a low concentration of amphotericin B to enable daunomycin entrapment.
- Assessing erythrocyte integrity and chemical parameters post-incubation.
- Administering daunomycin-loaded erythrocytes to mice bearing L1210 leukemia.
- Comparing survival rates with control groups.
Main Results:
- Daunomycin was successfully entrapped within erythrocytes upon incubation with amphotericin B.
- Erythrocyte hemolysis and chemical alterations were avoided.
- Mice treated with daunomycin-loaded erythrocytes showed a significant increase in survival compared to controls.
Conclusions:
- Low-concentration amphotericin B facilitates non-hemolytic daunomycin entrapment in erythrocytes.
- Erythrocytes can serve as effective carrier vehicles for daunomycin, enhancing its anti-leukemic efficacy.
- This erythrocyte-based drug delivery strategy shows promise for improving cancer therapy.
